RetractedPress releaseAnnouncedFederal
Branded GLP-1 prices keep falling as Medicare's $50 Bridge reaches 600,000 seniors
Source Sep 18, 2026Briefing Sep 22, 2026Reviewed Sep 22, 2026Next review Jan 31, 2027
Retracted September 22, 2026. Withdrawn by the editor the day it ran: a pricing and coverage development rather than a regulatory change, outside the scope of Regulatory Watch. The sources remain listed for the record. The original summary has been withdrawn; the sources below remain for the record.
01Sources
- Fact Sheet: President Donald J. Trump Announces Lower Drug Prices for All 50 State Medicaid Programs PrimaryThe White HouseRetrieved Sep 22, 2026
Paragraphs on the July 2026 senior GLP-1 program (600,000 seniors, $216 million), TrumpRx savings, and the 26 manufacturer agreements covering 89 percent of the branded market.
- CMS Launches Medicare GLP-1 Bridge, Expanding Access to GLP-1 Medications PrimaryCenters for Medicare and Medicaid ServicesRetrieved Sep 22, 2026
Press release of July 1, 2026: $50 a month for eligible Part D enrollees, available through December 31, 2027; eligibility limits.
- President Trump Extends Most-Favored-Nation Pricing to Every Medicaid Program in America PrimaryThe White HouseRetrieved Sep 22, 2026
GLP-1s start as low as $149; eligible Medicare seniors pay $50; more than 500,000 seniors and $216 million.
- CMS Announces Participants in Landmark Medicaid Drug Payment Model PrimaryCenters for Medicare and Medicaid ServicesRetrieved Sep 22, 2026
September 18, 2026: all 50 states, DC and Puerto Rico applied to the GENEROUS model.
All briefingsRevision 2783c18ae26a
Know where your pharmacy stands before the rules change again.
Certified pharmacies are re-verified nightly against state boards, federal enforcement records and their own websites.